PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24623N0478Pylarify f 18 — Progenics Pharmaceuticals, Inc

Progenics Pharmaceuticals, Inc holds $95.0M across 149 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79719D0170. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Dec 31, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

246-Network Contracting Office 6 (36C246)
Awarding office
Progenics Pharmaceuticals, Inc
Recipient
Dec 31, 2023
PoP end
$1M
Obligated
$1.9M
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Progenics Pharmaceuticals, Inc — $90

Contract facts

Federal
Contract number36C24623N0478
Also listed as36C246-23-N-0478
Also listed as36F79719D0170-36C24623N0478
Agency246-Network Contracting Office 6 (36C246)
Awarding office246-Network Contracting Office 6 (36C246)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentProgenics Pharmaceuticals, Inc
CAGE34KE9
UEIYLYKVRPCTCR3
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79719D0170
Place of performanceNORTH BILLERICA MA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startFeb 18, 2023
PoP end (current)Dec 31, 2023
Obligated$1M
Current value$1.9M
Potential value$1.9M

PYLARIFY F 18 is a federal award for 246-Network Contracting Office 6 (36C246) held by Progenics Pharmaceuticals, Inc. Estimated value $1.9M ($1M obligated). Current period of performance ends Dec 31, 2023. Last award drew 1 bidder. Place of performance: NORTH BILLERICA MA.

Recompete timing

Public
Past PoP end (964 days ago)

Current PoP ended Dec 31, 2023 (964 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Progenics Pharmaceuticals, Inc$95.0M obligated across 149 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($95.0M) · all agencies
Department of Veterans Affairs (VA)$93.8M · 99%Department of Health and Human Services (HHS)$1.1M · 1%Department of Defense (DOD)$105K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C24625N1142
PYLARIFY F-18 INJECTIONS (336)
$1.2M
Aug 31, 2026
75N90025F00021
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297]
$611K
Sep 25, 2026
36C26126N0023
480 F18 PYLARIFY DOSES POP 1/1/2025 - 12/31/2025
$1.7M
Sep 26, 2026
75N90025F00003
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO. [POTS 25-000073]
$2.1M
Sep 29, 2026
36C26122N0385
PYLARIFY (PIFLUFOLASTAT F18) NDC: 71258-0022-01
$4.5M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24623N0478?

36C24623N0478 (Pylarify f 18) is a 246-Network Contracting Office 6 (36C246) award with a potential value of $1.9M, currently held by Progenics Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C246-23-N-0478?

36C246-23-N-0478 is the dashed form of PIID 36C24623N0478 (Pylarify f 18), held by Progenics Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24623N0478?

246-Network Contracting Office 6 (36C246) awarded 36C24623N0478 to Progenics Pharmaceuticals, Inc (potential $1.9M).

Who is the incumbent on 36C24623N0478?

Progenics Pharmaceuticals, Inc is the incumbent with $95.0M across 149 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2023.

When does Progenics Pharmaceuticals, Inc’s 36C24623N0478 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24623N0478